FDA Committee OKs Psoriasis Drug For Kids
A U.S. Food and Drug Administration advisory committee has narrowly voted to recommend that the agency approve Amgen Inc.'s Enbrel for children despite concerns that the medication could cause serious side...To view the full article, register now.
Already a subscriber? Click here to view full article